Dysregulation of HSPC activity in the BM has been reported in several chronic inflammatory diseases, including inflammatory bowel disease, experimental spondyloarthritis, atherosclerosis and systemic lupus erythematosus (SLE)6–9. Here, PSMA7 is linked to atherosclerosis.